Anticancer Antibodies-Reference-Cited by-同舟云学术

Anticancer Antibodies

Published:2003-04 Issue:4 Volume:119 Page:472-485
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Ross Jeffrey S.,Gray Karen,Gray Gary S.,Worland Peter J.,Rolfe Mark

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/119/4/472/4985060/ajcpath119-0472.pdf

Reference91 articles.

1. Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells;Kirchner;Ann Oncol,2002

2. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium;Liu;Cancer Res,1997

3. Continuous cultures of fused cells secreting antibody of predefined specificity;Kohler;Nature,1975

4. Improving the efficacy of antibody-based cancer therapies;Carter, P;Nat Rev Cancer,2001

5. Baselga J. The EGFR as a target for anticancer therapy: focus on cetuximab. Eur J Cancer. 2001;37 suppl 4:S16-S22.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escherichia coli in the production of biopharmaceuticals;Biotechnology and Applied Biochemistry;2024-09-08

2. Amphiphilic Polypeptides Obtained by Post-Polymerization Modification of Poly-l-Lysine as Systems for Combined Delivery of Paclitaxel and siRNA;Pharmaceutics;2023-04-21

3. Cancer therapeutic drug guide;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

4. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities;Journal of Cellular Physiology;2021-09-08

5. Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities;Seminars in Cancer Biology;2020-11